780 related articles for article (PubMed ID: 21635149)
1. Anthracycline cardiotoxicity.
Menna P; Paz OG; Chello M; Covino E; Salvatorelli E; Minotti G
Expert Opin Drug Saf; 2012 May; 11 Suppl 1():S21-36. PubMed ID: 21635149
[TBL] [Abstract][Full Text] [Related]
2. An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies.
Zerra P; Cochran TR; Franco VI; Lipshultz SE
Expert Opin Pharmacother; 2013 Aug; 14(11):1497-513. PubMed ID: 23705955
[TBL] [Abstract][Full Text] [Related]
3. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity.
Minotti G; Menna P; Salvatorelli E; Cairo G; Gianni L
Pharmacol Rev; 2004 Jun; 56(2):185-229. PubMed ID: 15169927
[TBL] [Abstract][Full Text] [Related]
4. In vitro modeling of the structure-activity determinants of anthracycline cardiotoxicity.
Menna P; Minotti G; Salvatorelli E
Cell Biol Toxicol; 2007 Jan; 23(1):49-62. PubMed ID: 17031515
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of cardiotoxicity induced by anthracyclines.
Elliott P
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S2-7. PubMed ID: 16781283
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced cardiotoxicity in children.
Bansal N; Amdani S; Lipshultz ER; Lipshultz SE
Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):817-832. PubMed ID: 28679288
[TBL] [Abstract][Full Text] [Related]
7. Prevention of anthracycline-induced cardiotoxicity in children: the evidence.
van Dalen EC; Caron HN; Kremer LC
Eur J Cancer; 2007 May; 43(7):1134-40. PubMed ID: 17383867
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity and cardioprotection in childhood cancer.
Lipshultz SE; Sambatakos P; Maguire M; Karnik R; Ross SW; Franco VI; Miller TL
Acta Haematol; 2014; 132(3-4):391-9. PubMed ID: 25228565
[TBL] [Abstract][Full Text] [Related]
9. Biomarker approach to the detection and cardioprotective strategies during anthracycline chemotherapy.
Ky B; Carver JR
Heart Fail Clin; 2011 Jul; 7(3):323-31. PubMed ID: 21749884
[TBL] [Abstract][Full Text] [Related]
10. Cardiac complications in childhood cancer survivors treated with anthracyclines.
Franco VI; Lipshultz SE
Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
[TBL] [Abstract][Full Text] [Related]
11. [Cardiotoxicity of anthracyclines: mechanisms and pharmacologic targets for prevention].
Andrieu-Abadie N
Therapie; 2004; 59(1):121-6. PubMed ID: 15199678
[TBL] [Abstract][Full Text] [Related]
12. Anthracycline cardiotoxicity: from bench to bedside.
Gianni L; Herman EH; Lipshultz SE; Minotti G; Sarvazyan N; Sawyer DB
J Clin Oncol; 2008 Aug; 26(22):3777-84. PubMed ID: 18669466
[TBL] [Abstract][Full Text] [Related]
13. Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities.
Vejpongsa P; Yeh ET
J Am Coll Cardiol; 2014 Sep; 64(9):938-45. PubMed ID: 25169180
[TBL] [Abstract][Full Text] [Related]
14. Genotyping the risk of anthracycline-induced cardiotoxicity.
Deng S; Wojnowski L
Cardiovasc Toxicol; 2007; 7(2):129-34. PubMed ID: 17652817
[TBL] [Abstract][Full Text] [Related]
15. Anticancer agents and cardiotoxicity.
Ng R; Better N; Green MD
Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642
[TBL] [Abstract][Full Text] [Related]
16. Cardiotoxic consequences of anthracycline-containing therapy in patients with breast cancer.
Jensen BV
Semin Oncol; 2006 Jun; 33(3 Suppl 8):S15-21. PubMed ID: 16781285
[TBL] [Abstract][Full Text] [Related]
17. Maximizing anthracycline tolerability in hematologic malignancies: Treat to each heart's content.
Oliveira GH; Al-Kindi SG; Caimi PF; Lazarus HM
Blood Rev; 2016 May; 30(3):169-78. PubMed ID: 26578029
[TBL] [Abstract][Full Text] [Related]
18. [Ranolazine in the prevention of anthracycline-related cardiotoxicity].
Corradi F; Paolini L; De Caterina R
G Ital Cardiol (Rome); 2013 Jun; 14(6):424-37. PubMed ID: 23748539
[TBL] [Abstract][Full Text] [Related]
19. New iron chelators in anthracycline-induced cardiotoxicity.
Kaiserová H; Simunek T; Sterba M; den Hartog GJ; Schröterová L; Popelová O; Gersl V; Kvasnicková E; Bast A
Cardiovasc Toxicol; 2007; 7(2):145-50. PubMed ID: 17652820
[TBL] [Abstract][Full Text] [Related]
20. Anthracycline-related cardiotoxicity in childhood cancer survivors.
Lipshultz SE; Karnik R; Sambatakos P; Franco VI; Ross SW; Miller TL
Curr Opin Cardiol; 2014 Jan; 29(1):103-12. PubMed ID: 24284979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]